Oglobine J, Spyratos F, Lidereau R, Brault C, Desplaces A
Cancer Detect Prev. 1985;8(1-2):67-70.
The activities of selected glycolytic enzymes in breast tumor tissues were examined based on earlier studies showing a relationship between therapy and/or prognosis of breast cancer and tissue enzyme. In the present study, five glycolytic enzymatic activities (pyruvate kinase [PK], glucose-6-phosphate dehydrogenase [G6PD], phosphohexose-isomerase [PHI], lactate dehydrogenase [LDH], and 6-phospho-glucocate dehydrogenase [6PGD]) were measured in the cytosol (105,000 g) of 57 breast carcinomas and 22 benign breast lesions. Nucleic acids and DNA were also determined. The results were related to the wet weight of the tissue, to total and tissue cytosol proteins, and to DNA. The various means of expressing the results were compared. The correlations were satisfactory except for PHI and LDH. In these cases, this might have been due to blood contamination. The enzyme activities content was lower in the benign breast lesions than in the breast carcinomas irrespective of the way the results were expressed.
基于早期研究显示乳腺癌的治疗和/或预后与组织酶之间存在关联,对乳腺肿瘤组织中选定的糖酵解酶活性进行了检测。在本研究中,测定了57例乳腺癌和22例乳腺良性病变的细胞溶质(105,000g)中的五种糖酵解酶活性(丙酮酸激酶[PK]、葡萄糖-6-磷酸脱氢酶[G6PD]、磷酸己糖异构酶[PHI]、乳酸脱氢酶[LDH]和6-磷酸葡萄糖酸脱氢酶[6PGD])。还测定了核酸和DNA。结果与组织湿重、总蛋白和组织细胞溶质蛋白以及DNA相关。比较了表达结果的各种方式。除了PHI和LDH外,相关性令人满意。在这些情况下,这可能是由于血液污染所致。无论结果如何表达,乳腺良性病变中的酶活性含量均低于乳腺癌。